Patent infringement cases filed by Bayer Healthcare LLC against Abbott Laboratories relating to Humira(R} were settled during the second quarter of 2011.
In its 2010 Form 10-K, Abbott reported that lawsuits…
A patent infringement suit filed by Abbott Laboratories against Lupin Pharmaceuticals and Lupin Limited relating to Niaspan(R) was settled and dismissed with prejudice during the second quarter of 2011.
In its…
Centocor Inc. has until Sept. 12, 2011 to ask the U.S. Supreme Court to review the Federal Circuit’s decision in a patent infringement suit it filed against Abbott Laboratories.
In April…
Abbott Laboratories obtained favorable ruling in a patent infringement suit filed by Medinol Limited.
In its Form 10-Q for the quarter ended March 31, 2011, Abbott reported that in March 2011…
Abbott Laboratories is seeking to enforce its patent rights relating to testosterone gel product, a drug that the Company sells under the trademark AndroGel(R).
In a case filed in the United…
Patent infringement suits filed by Abbott Laboratories against Impax Laboratories and Teva Pharmaceuticals USA Inc. relating to Tricor(R) were settled and dismissed with prejudice during the second quarter of 2011.
In…
Abbott Laboratories continues to defend itself against a patent infringement suit filed by Medinol Limited.
In its 2010 Form 10-K, Abbott reported that litigation is pending in the Regional Court in…
A patent infringement suit filed by New York University and Centocor, Inc., against Abbott Laboratories remains pending. The suit asserts that adalimumab — a drug Abbott sells under the trademark…
Patent infringement suits filed by Johnson & Johnson, Inc., Cordis Corporation, a wholly owned subsidiary of Johnson & Johnson, and Wyeth against Abbott Laboratories related to Xience V stent remain…
Abbott Laboratories’ patent infringement suit against Centocor Inc. relating to Simponi(R) is pending.
Abbott is seeking to enforce certain patent rights that cover the use of fully human anti-TNF alpha antibodies…